Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$47.74 -4.50 (-8.61%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$47.73 -0.01 (-0.02%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. CDRE, LQDA, INMD, PLSE, BLFS, AORT, MDXG, RXST, FNA, and BFLY

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Cadre (CDRE), Liquidia (LQDA), InMode (INMD), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Artivion (AORT), MiMedx Group (MDXG), RxSight (RXST), Paragon 28 (FNA), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

Semler Scientific vs.

Cadre (NYSE:CDRE) and Semler Scientific (NASDAQ:SMLR) are both small-cap industrial products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

Semler Scientific has a net margin of 72.65% compared to Cadre's net margin of 6.34%. Semler Scientific's return on equity of 50.77% beat Cadre's return on equity.

Company Net Margins Return on Equity Return on Assets
Cadre6.34% 12.88% 6.06%
Semler Scientific 72.65%50.77%47.04%

44.0% of Cadre shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 37.0% of Cadre shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cadre has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cadre$482.53M2.83$38.64M$0.8340.58
Semler Scientific$56.29M7.86$20.58M$4.919.72

Cadre received 14 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 55.17% of users gave Cadre an outperform vote.

CompanyUnderperformOutperform
CadreOutperform Votes
16
55.17%
Underperform Votes
13
44.83%
Semler ScientificOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

Cadre has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

In the previous week, Semler Scientific had 7 more articles in the media than Cadre. MarketBeat recorded 8 mentions for Semler Scientific and 1 mentions for Cadre. Semler Scientific's average media sentiment score of 0.80 beat Cadre's score of 0.70 indicating that Semler Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cadre
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Semler Scientific
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cadre currently has a consensus price target of $39.67, suggesting a potential upside of 17.76%. Semler Scientific has a consensus price target of $71.00, suggesting a potential upside of 48.72%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Semler Scientific is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cadre
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Semler Scientific beats Cadre on 11 of the 18 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$442.55M$3.40B$5.77B$8.95B
Dividend YieldN/A1.65%4.78%3.85%
P/E Ratio9.7216.9626.4618.81
Price / Sales7.8674.90449.1576.64
Price / Cash16.9445.9944.0437.47
Price / Book4.573.867.634.64
Net Income$20.58M$92.00M$3.18B$245.69M
7 Day Performance-3.89%4.33%-1.82%-2.63%
1 Month Performance-26.49%7.66%0.22%-2.37%
1 Year Performance3.67%13.25%17.49%13.65%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
3.2334 of 5 stars
$47.74
-8.6%
$71.00
+48.7%
+3.7%$442.55M$56.29M9.72120Earnings Report
CDRE
Cadre
2.936 of 5 stars
$35.14
-1.6%
$39.67
+12.9%
-5.2%$1.43B$482.53M42.342,435
LQDA
Liquidia
2.0617 of 5 stars
$16.20
+0.4%
$25.38
+56.6%
+13.0%$1.37B$17.49M-9.9450
INMD
InMode
2.0758 of 5 stars
$18.81
-1.3%
$22.25
+18.3%
-9.3%$1.31B$394.82M8.00480Positive News
PLSE
Pulse Biosciences
1.4648 of 5 stars
$20.99
-2.0%
N/A+108.2%$1.29B$700,000.000.00140News Coverage
BLFS
BioLife Solutions
1.7259 of 5 stars
$27.77
+2.3%
$29.43
+6.0%
+52.4%$1.29B$143.27M-26.20440
AORT
Artivion
1.4419 of 5 stars
$30.08
-0.2%
$31.80
+5.7%
+44.6%$1.26B$354M-1,503.951,500
MDXG
MiMedx Group
3.0099 of 5 stars
$8.40
+1.4%
$12.00
+42.9%
-1.0%$1.23B$321.48M15.27870
RXST
RxSight
2.6433 of 5 stars
$29.81
-6.5%
$58.13
+95.0%
-46.2%$1.20B$128.29M-35.92220Upcoming Earnings
FNA
Paragon 28
2.0598 of 5 stars
$13.06
0.0%
$14.60
+11.8%
-4.2%$1.09B$216.39M-17.64343,000
BFLY
Butterfly Network
1.4126 of 5 stars
$4.77
+2.5%
$3.00
-37.0%
+323.3%$1.02B$65.90M-10.36460

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners